Table 1 Patient Characteristics
Age (year) | 66 (48–80) |
T stage (UICC 2009) | |
T1c | 83 (27%) |
T2a-b | 86 (28%) |
T2c | 60 (20%) |
T3a | 69 (23%) |
T3b | 6 (2%) |
Gleason Score | |
6 | 20 (7%) |
7 | 171 (56%) |
3 + 4 | 97 (32%) |
4 + 3 | 74 (24%) |
8 | 36 (12%) |
9 | 71 (23%) |
10 | 6 (2%) |
PSA (ng/ml) | |
< 10 | 195 (64%) |
10–20 | 75 (25%) |
≧20 | 33 (11%) |
Risk group | |
Low | 16 (5%) |
Intermediate | 142 (47%) |
High | 146 (48%) |
ADT | |
No | 66 (22%) |
Yes | 238 (78%) |